How many clinical-trial readouts are scheduled for August 2026?

pdufa.bio currently tracks 40 clinical-trial readouts with dates in August 2026, each linked to a primary source. The list updates as new filings appear and dates shift.

What is a clinical-trial readout date?

A readout date is the estimated time a trial reports topline results, based on its registered primary-completion date; these are estimates and shift.

Does pdufa.bio predict whether these will be approved?

No. We do not publish per-drug approval probabilities. We provide the verified facts, primary-source links, and historical base rates so you can judge for yourself.

pdufa.bio

Calendar Readouts Devices Decisions Approvals/yr Trial odds Learn Research Methodology

Home › Readouts › August 2026

August 2026 clinical-trial readouts

trial-readout estimates for August 2026, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.

← July 2026 September 2026 →

40 readouts

IVVD · Aug 2026 (est.)

VYD2311 — COVID-19

GPCR · Aug 2026 (est.)

aleniglipron — Obesity, Overweight, or Chronic Weight Management

GRFS · Aug 2026 (est.)

ALPHA-1 MP — Pulmonary Emphysema in Alpha-1 PI Deficiency

HELP · Aug 2026 (est.)

CYB003 — Major Depressive Disorder

IGC · Aug 2026 (est.)

IGC-AD1-Active — Alzheimer Disease

KOD · Aug 2026 (est.)

Tarcocimab Tedromer — Wet Age-related Macular Degeneration

KPTI · Aug 2026 (est.)

Selinexor — Endometrial Cancer

KURA · Aug 2026 (est.)

Ziftomenib — AML

KYTX · Aug 2026 (est.)

Standard of Care Treatment — Lupus Nephritis

MANE · Aug 2026 (est.)

VDPHL01 — Androgenetic Alopecia

CADL · Aug 2026 (est.)

Aglatimagene Besadenovec — Prostate Cancer Patients Treated by Radiotherapy

CORT · Aug 2026 (est.)

Relacorilant — Ovarian Cancer

CRIS · Aug 2026 (est.)

chondrocyte-alginate gel suspension — Relapsed Hematologic Malignancy

DFTX · Aug 2026 (est.)

DT120 — Generalized Anxiety Disorder

ENSC · Aug 2026 (est.)

PF614 capsule — Postoperative Pain, Acute

EYPT · Aug 2026 (est.)

EYP-1901 — Wet Age Related Macular Degeneration

MIRM · Aug 2026 (est.)

Brelovitug — Chronic Hepatitis D Infection

MPLT · Aug 2026 (est.)

ML-007C-MA — Schizophrenia

ACRS · Aug 2026 (est.)

A-101 — Atopic Dermatitis

XENE · Aug 2026 (est.)

Azetukalner — Major Depressive Disorder

NCNA · Aug 2026 (est.)

NUC-1031 — Advanced Cancer

NVO · Aug 2026 (est.)

Semaglutide — NAFLD

PHVS · Aug 2026 (est.)

deucrictibant — Hereditary Angioedema (HAE)

RGNX · Aug 2026 (est.)

Ranibizumab — Neovascular Age-Related Macular Degeneration (nAMD)

RIGL · Aug 2026 (est.)

Fostamatinib Disodium — Low Risk Myelodysplastic Syndromes

TMO · Aug 2026 (est.)

MK-7240 — Ulcerative Colitis

BMRN · Aug 2026 (est.)

Vosoritide — Hypochondroplasia

BIVI · Aug 2026 (est.)

NE3107 — Long COVID

AKBA · Aug 2026 (est.)

Vadadustat — Anemia of Chronic Kidney Disease

ANRO · Aug 2026 (est.)

ALTO-100 — Bipolar Disorder I or II With a Major Depressive Episode

MRK · Aug 2026 (est.)

Ensifentrine — Chronic Obstructive Pulmonary Disease

INCY · Aug 2026 (est.)

Ruxolitinib — NonSegmental Vitiligo

ACRV · Aug 2026 (est.)

ACR-368 — Specific Advanced Solid Tumors

JSPR · Aug 2026 (est.)

Briquilimab — Urticaria Chronic

TMO · Aug 2026 (est.)

Nexium — Erosive Esophagitis

PMVP · Aug 2026 (est.)

rezatapopt — Advanced Solid Tumor

CLRB · Aug 2026 (est.)

NOV-002 — Pediatric Solid Tumor

MSLE · Aug 2026 (est.)

SAT-3247 — Duchenne Muscular Dystrophy (DMD)

VSTM · Aug 2026 (est.)

avutometinib — KRAS Activating Mutation

NRIX · Aug 2026 (est.)

NX-5948 — Ovarian Cancer, Epithelial

Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).